The Hon. Bill Baer

Bill Baer is a visiting fellow in Governance Studies at the Brookings Institute. He is one of the world’s best known and respected antitrust/competition enforcers. Bill is the only person to have led antitrust enforcement at both U.S. antitrust agencies, serving as Assistant Attorney General in charge of the Antitrust Division of the US Department of Justice from 2013 to 2016, and as Director of the Bureau of Competition at the Federal Trade Commission from 1995 to 1999.

Bill worked at the Federal Trade Commission on two different occasions: from 1995-99, as Director of the Bureau of Competition; and from 1975-1980 as Attorney Advisor to the Chairman and Assistant General Counsel for Legislation and Congressional Relations. While not in public service Bill headed the highly regarded antitrust practice at Arnold & Porter, representing a broad range of companies in US and international cartel investigations, antitrust litigation, and mergers and acquisition reviews by antitrust enforcers, including the DOJ, FTC, state attorneys general, and the European Commission.

Bill received his JD in 1975 from Stanford Law School, where he served as Senior Article Editor of The Stanford Law Review, and his BA in 1972 from Lawrence University, which recently awarded him its Distinguished Alumni Achievement Award.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More